Family Fair
–
Bring the whole brood to Family Fair 2026 as we welcome Daniel Tiger! Children of all ages enjoy BrainHealth Week with a whirlwind journey into the human brain with games, food, arts & crafts, and surprises. An annual favorite, this free community event offers short, interactive talks and unique family engagement activities. Explore the concept of cognitive control, a superpower that helps us behave, think and learn in different environments. Please register to attend.
Understanding the Importance of Preventing Alzheimer’s Disease and Supporting Brain Health
–
We have made great strides in understanding the biology of Alzheimer’s Disease and learning how to detect and even treat it at the earliest stages when we expect treatment to be most effective. Dr. Mary Sano, PhD, is professor of psychiatry and the director of the Alzheimer's disease research at Mount Sinai School of Medicine, provides an update on the progress of treating and preventing Alzheimer’s dementia.
An Entorhinal Cortex Circuit in Cocaine Memories
–
Drug-associated memories can be a major driver of relapse in addiction. UTD neuroscience professor Dr. Andrew Eagle focuses on researching how the brain encodes and retrieves drug-cue memories that promote maladaptive behavior. He presents preliminary findings demonstrating that the entorhinal cortex (EC) plays a critical role in this process and explores the broader research goal of defining the neural mechanisms by which memory shapes motivation in addiction.
NEW DATE: From Data to Diagnosis: Computational Psychiatry and Brain Imaging in the Age of AI
–
NEW DATE: Computational psychiatry is reshaping our understanding of mental illness by integrating data-driven modeling with neurobiological insights. Andrew Michael, PhD, of Duke University examines the evolving role of brain imaging and AI in computational psychiatry, emphasizing their transformative promise, pitfalls, and path forward.
MRI Biomarkers for Vascular Cognitive Impairment and Dementia
–
Brain imaging provides an important opportunity for diagnosis, prognosis and treatment monitoring in vascular cognitive impairment and dementia (VCID). In this talk, Dr. Hanzhang Lu discusses a potential framework of biomarkers for the classification of vascular cognitive impairment and dementia (VCID), specifically describing cerebrovascular reactivity (CVR), an important physiological parameter of vascular health, as a candidate biomarker in small vessel disease related VCID.